DEBORAH UPLINGER: Open Payments
NPI 1437165743 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 10 payments from 8 companies in 2025. Trend: 2023 $140 · 2024 $370 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $25 |
| Viatris Specialty LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: JARDIANCE, STRENSIQ, Veozah, FARXIGA, YUPELRI, NEXLETOL, XIFAXAN.
Industry payments across MO — which companies pay providers there.
